Return On Equity of Y-mAbs Therapeutics, Inc. from 30 Sep 2018 to 30 Jun 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Y-mAbs Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2018 to 30 Jun 2025.
  • Y-mAbs Therapeutics, Inc. Return On Equity for the quarter ending 30 Jun 2025 was -25%, a 1.2% increase year-over-year.
  • Y-mAbs Therapeutics, Inc. annual Return On Equity for 2024 was -31%, a 51% decline from 2023.
  • Y-mAbs Therapeutics, Inc. annual Return On Equity for 2023 was -21%, a 73% increase from 2022.
  • Y-mAbs Therapeutics, Inc. annual Return On Equity for 2022 was -76%, a 200% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Y-mAbs Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2025 -25% 0% +1.2% 01 Apr 2025 30 Jun 2025
Q1 2025 -31% -9% -43% 01 Jan 2025 31 Mar 2025
Q4 2024 -31% -11% -51% 01 Oct 2024 31 Dec 2024
Q3 2024 -25% -6% -35% 01 Jul 2024 30 Sep 2024
Q2 2024 -25% +11% +32% 01 Apr 2024 30 Jun 2024
Q1 2024 -21% +43% +67% 01 Jan 2024 31 Mar 2024
Q4 2023 -21% +55% +73% 01 Oct 2023 31 Dec 2023
Q3 2023 -18% +74% +80% 01 Jul 2023 30 Sep 2023
Q2 2023 -36% +43% +54% 01 Apr 2023 30 Jun 2023
Q1 2023 -65% -5% -8.5% 01 Jan 2023 31 Mar 2023
Q4 2022 -76% -50% -200% 01 Oct 2022 31 Dec 2022
Q3 2022 -93% -74% -386% 01 Jul 2022 30 Sep 2022
Q2 2022 -79% -56% -233% 01 Apr 2022 30 Jun 2022
Q1 2022 -60% -21% -55% 01 Jan 2022 31 Mar 2022
Q4 2021 -25% +63% +71% 01 Oct 2021 31 Dec 2021
Q3 2021 -19% +58% +75% 01 Jul 2021 30 Sep 2021
Q2 2021 -24% +51% +68% 01 Apr 2021 30 Jun 2021
Q1 2021 -39% +26% +40% 01 Jan 2021 31 Mar 2021
Q4 2020 -88% -25% -41% 01 Oct 2020 31 Dec 2020
Q3 2020 -77% -14% -23% 01 Jul 2020 30 Sep 2020
Q2 2020 -75% -30% -67% 01 Apr 2020 30 Jun 2020
Q1 2020 -64% -22% -51% 01 Jan 2020 31 Mar 2020
Q4 2019 -62% -23% -57% 01 Oct 2019 31 Dec 2019
Q3 2019 -63% -22% -53% 01 Jul 2019 30 Sep 2019
Q2 2019 -45% 01 Apr 2019 30 Jun 2019
Q1 2019 -43% 01 Jan 2019 31 Mar 2019
Q4 2018 -40% 01 Oct 2018 31 Dec 2018
Q3 2018 -41% 01 Jul 2018 30 Sep 2018

Y-mAbs Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -31% -11% -51% 01 Jan 2024 31 Dec 2024
2023 -21% +55% +73% 01 Jan 2023 31 Dec 2023
2022 -76% -50% -200% 01 Jan 2022 31 Dec 2022
2021 -25% +63% +71% 01 Jan 2021 31 Dec 2021
2020 -88% -25% -41% 01 Jan 2020 31 Dec 2020
2019 -62% -23% -57% 01 Jan 2019 31 Dec 2019
2018 -40% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.